Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
15 November 1996 | Volume 125 Issue 10 | Pages 794-798
Background: Surprisingly, many inner-city residents have antibodies to Leptospira interrogans. The manner in which these persons acquire this organism in the absence of recognized occupational, recreational, or epidemic risk factors is not known.
Objective: To study the epidemiology of patients with leptospirosis who acquired L. interrogans in inner-city Baltimore, Maryland.
Design: Epidemiologic investigation.
Setting: Inner-city university hospital.
Patients: Three inner-city residents who developed leptospirosis.
Measurements: Trapping rats in alleys where the patients may have acquired L. interrogans; polymerase chain reaction (PCR) analysis of patient serum and cerebrospinal fluid specimens and rat tissues to determine the presence of leptospiral DNA; and serologic testing of serum from patients and rats by microagglutination assay to confirm L. interrogans infection.
Results: Three patients developed leptospirosis after probable percutaneous exposure to rat (Rattus norvegicus) urine in Baltimore alleys. A PCR assay detected L. interrogans DNA in samples of body fluid obtained from the first two patients at presentation (one in cerebrospinal fluid, the other in serum). Results of PCR done on serum drawn from the third patient after antibiotic therapy began were negative. A microagglutination test showed that all patients had high levels of antibodies to the L. interrogans serogroup lcterohaemorrhagiae. In 19 of 21 rats that were trapped in the alleys where the patients had sustained lacerations before illness developed, kidney or brain tissues were positive by PCR for the presence of L. interrogans.
Conclusions: A population was discovered to be at risk for acquiring L. interrogans: urban residents who are sporadically exposed to rat urine in the inner city. Inner-city rats often carry L. interrogans. Polymerase chain reaction can quickly establish the diagnosis of leptospirosis and is useful for epidemiologic study. An endemic substrate for the transmission of the organism is present in inner-city Baltimore. Leptospirosis may become increasingly recognized in deteriorating inner cities in which rat populations are expanding.
The mechanism by which L. interrogans is transmitted sporadically in cities in the absence of occupational and recreational exposure is not known. We report the epidemiology of three confirmed cases of leptospirosis that occurred in Baltimore, Maryland, and we show a hitherto unrecognized population at risk for acquiring L. interrogans.
Polymerase Chain Reaction
Samples of DNA were extracted from the brains and kidneys of rats and from pellets of centrifuged human cerebrospinal fluid and serum using the QIAGEN QIAAmp Tissue Kit 29306 (QIAGEN, Chatsworth, California). Special precautions were used to avoid cross-contamination, which can cause false-positive results; these precautions included the use of aerosol-filtered pipette tips and different locations for DNA preparation and handling of PCR products. Polymerase chain reaction was done on L. interrogans by using a published primer set and cycling protocol [9]. Primers G1 (5' CTGAATCGCT GTATAAAAGT) and G2 (5' GGAAAACAAA TG GTCGGAAG) are specific for pathogenic leptospiraceae [9]. The L. interrogans serovar autumnalis (American Type Culture Collection, catalog 23476, Rockville, Maryland) was used as a positive control in the PCR experiments. The PCR mixtures were subjected to electrophoresis in 3% 3:1 NuSieve (FMC Bioproducts, Rockland, Maine) agarose gels in Tris-acetate-ethylenediaminetetraacetic acid buffer. Bands of DNA of the appropriate size were purified and cloned as described elsewhere [10]. The Biopolymer Laboratory of the Howard Hughes Medical Institute at the Johns Hopkins School of Medicine sequenced DNA with the dye-terminator method using an automated DNA sequencer (Applied Biosystems Model 373, Perkin-Elmer Corp., Foster City, California) with Taq polymerase (Boehringer Mannheim, Indianapolis, Indiana).
Serologic Testing
The presence of antibodies to L. interrogans was determined by the microagglutination test. Live spirochetes were used as antigen [11], and testing was done at the CDC. The panel of antigens included the following 20 serovars: ballum, canicola, icterohaemorrhagiae, bataviae, grippotyphosa, pyrogenes, autumnalis, pomona, wolffi, australis, tarassovi, georgia, alexi, cynopteri, mankarso, celledoni, djasiman, borincana, javanica, and bratislava. The serovars icterohaemorrhagiae and mankarso are members of the serogroup Icterohaemorrhagiae. The titers reported here are the highest dilution that produced agglutination of at least 50% of the leptospires relative to the phosphate-buffered saline control. Titers of 1:100 or greater were considered positive.
Three patients with confirmed leptospirosis were seen in Baltimore, Maryland, between November 1993 and October 1995 (Table 1). All had abrupt onset of symptoms, which were typically fever and severe leg pain and weakness. Accompanying manifestations included meningitis, hemorrhagic diathesis, jaundice, acute renal insufficiency with nephritis, and thrombocytopenia. ARTICLE
Sporadic Urban Leptospirosis
Leptospirosis, a zoonosis that occurs throughout the world but is most commonly seen in tropical climates [1], is caused by numerous serovars of the spirochete Leptospira interrogans. Humans contract the disease through contact with the urine of infected animals. In the United States, where the disease is rarely recognized, rats, dogs, and farm livestock are the most common carriers of L. interrogans [2]. Clinical manifestations are protean, ranging from an influenza-like illness to fulminant disease with jaundice, acute renal failure, aseptic meningitis, and hemorrhagic diathesis (Weil disease) [2-4]. Most cases of leptospirosis probably remain unrecognized unless the diagnosis is suggested by a specific epidemiologic exposure or the disease occurs in the context of an outbreak [2-5]. Most exposures involve water [5], are recreational (for example, swimming in fresh water and camping), and are occupational (for example, veterinary, agricultural, or sewer work and meat processing) [2-5]. A recent study from Italy [6] has suggested that additional risk factors of urban dwellers who develop leptospirosis remain to be identified. The disease can spread epidemically through large populations when such natural disasters as floods occur; this was seen in the recent epidemic of fever with pulmonary hemorrhage associated with leptospirosis in rural Nicaragua [7, 8]. In 1995, the Council of State and Territorial Epidemiologists and the U.S. Centers for Disease Control and Prevention [CDC] removed leptospirosis from the United States' list of notifiable diseases for the following reasons: 1) Reliable diagnostic testing is not readily available in the United States; 2) organized reporting in the United States has not resulted in the implementation of activities to control disease; 3) many states have not reported the disease, resulting in substantial under-reporting; and 4) other diseases needed to be added to the list without placing an undue burden on clinicians, counties, and states (Spiegel R. Personal communication).
Methods
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
Our study was approved by the Joint Committee on Clinical Investigation of the Johns Hopkins Medical Institutions. Sprague-Dawley rats (Rattus norvegicus) (Jackson Laboratory, Bar Harbor, Maine) were used as controls for the polymerase chain reaction (PCR) and microagglutination assays. Feral rats (R. norvegicus) were trapped alive in the alleys where the patients probably became infected. The rats were anesthetized with methoxyflurane and ketamine before blood and tissue samples were obtained. Separate sterile surgical instruments were used to obtain specimens from the kidney and brain. Human serum and cerebrospinal fluid samples were obtained from clinical specimens taken for routine clinical purposes from patients suspected of having leptospirosis and from patients with unrelated illnesses (negative controls).
Results
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
Clinical Manifestations on Initial Presentation
|
Epidemiology and Potential Exposure to Leptospira interrogans
All three patients lived in inner-city Baltimore. None had recently traveled outside of Baltimore, had been exposed to farm animals, or had pets. After extensive questioning, the patients described clear exposure to feral urban rats. Patient 1 had walked barefoot in inner-city alleys where she had seen rats. She recalled stepping on glass 10 days before the onset of illness, and a healing laceration was seen on the plantar surface of her right foot. Patient 2 remembered cutting his hand on glass in a rat-infested alley about 10 days before the onset of illness. Patient 3 reported that he had walked barefoot in alleys near the harbors in downtown Baltimore, where he had previously seen rats.
Diagnosis
In all three patients, leptospirosis was confirmed by microagglutination testing. The results of leptospiral cultures done on specimens from the three patients were negative; all patients had received antibiotics before specimens were taken.
Cerebrospinal fluid from patient 1 (drawn on day 7 of illness) and serum from patient 2 (drawn on day 3 of illness) were analyzed by PCR (both specimens were obtained before the administration of antibiotics). Primers G1/G2 generated the predicted 285-base pair fragment specific for L. interrogans in the cerebrospinal fluid of patient 1 and the serum of patient 2 (data not shown). Serum from patient 3, taken several days after the initiation of antibiotic therapy, was negative by PCR. Cerebrospinal fluid and serum from five randomly selected patients who did not have leptospirosis (negative controls) were negative by PCR. Sequencing of the DNA in the positive bands confirmed that the DNA was from L. interrogans (data not shown).
Epidemiology of the Rat Vectors of Leptospirosis
Rats were trapped in the alleys that patients 1 and 2 reported were the likely location of their exposure to rat urine. Between January 1995 and March 1995, 18 rats were trapped from the alleys identified by patient 1; in April 1995, 3 rats were trapped from the alleys identified by patient 2. Polymerase chain reaction indicated that all 18 rats from the first site and 1 of the rats from the second site carried L. interrogans in the kidney or brain Table 2. Two laboratory-reared rats serving as negative controls were negative by PCR. Sequencing of the 285-base pair DNA fragment from several of these rats' tissues confirmed that the DNA was from L. interrogans (data not shown).
|
Microagglutination testing confirmed that the rats had been exposed to L. interrogans: Of the 18 rats trapped from the first site, 8 had antibodies to L. interrogans; the highest titer was against the serovar icterohaemorrhagiae (Table 2). Two laboratory-reared rats that served as negative controls were seronegative by microagglutination testing.
Discussion
|
|---|
|
|
|---|
We described three sporadic urban cases of leptospirosis. These patients acquired L. interrogans at different times and locations in an inner city; the only apparent risk factors were probable percutaneous exposure to rat urine in alleys. This mode of transmission is consistent with the fact that rats are known carriers of L. interrogans.
The patients we describe had complex systemic illnesses typical of leptospirosis. The most notable aspect of these casesthe presence of the disease in urban residentscreated confusion among the physicians caring for the patient: Until the diagnosis was established, most of the clinicians caring for the first patient were unaware that leptospirosis could develop in urban environments. The first case was correctly diagnosed by the house officers caring for the patient on the day of admission on the basis of the typical clinical and laboratory features of leptospirosis. Because the attending physician and several faculty consultants (specialists in infectious disease, nephrology, and hepatology) rejected the diagnosis of leptospirosis in favor of possible diagnoses related to the patient's sexual and substance abuse behaviors, the patient had extensive testing, including liver biopsy. Because of the institution's experience with the first patient, the second and third cases were correctly diagnosed early in the course of illness and were treated appropriately. A fourth case of infection with urban-acquired L. interrogans was reported to the Maryland State Department of Health (and confirmed by microagglutination testing at the CDC) late in October 1995: A 47-year-old homeless man acquired L. interrogans from swimming in the Jones Falls, a waterway in central Baltimore (Goodman J. Personal communication).
We showed by PCR and serologic testing that most of the rats trapped in alleys where the patients reported their probable exposures were infected with L. interrogans. Rat populations in Baltimore and other large cities probably have a high prevalence of L. interrogans infection. No previous study has shown that persons whose only risk factor for acquiring L. interrogans is living in an inner city are at risk for acquiring the organism. Thus, the epidemiology of human infection by L. interrogans may include sporadic contact with rat urine; this could also represent one of the unidentified risk factors for leptospirosis in urban dwellers suggested by an Italian study [6].
We also found that PCR is useful for early, rapid diagnosis of leptospirosis. The first two patients in our study had PCR-detectable L. interrogans DNA in body fluids early in the course of illness. With appropriate clinical suspicion, PCR can be used to establish a diagnosis early so that specific therapy can be initiated and invasive and expensive testing can be avoided. The use of PCR to diagnose of leptospirosis may eliminate the need for microagglutination testing and culture, which are cumbersome and delay diagnosis. However, before PCR can be adopted as the diagnostic method of choice, further prospective study is needed [15].
In our study, more rats were positive for leptospiral infection by PCR than by microagglutination testing, suggesting that some PCR results could have been false-positive because of cross-contamination by amplified leptospiral DNA. However, a similar discrepancy between rat seronegativity and culture positivity of rat tissues has been reported previously and suggests that rats chronically infected with L. interrogans can become seronegative. Feigin and colleagues [16] trapped rats while investigating an outbreak of leptospirosis in humans and canines. Of nine rats that were positive by culture of either brain or kidney, only three were positive by microagglutination assay. Other studies have had similar results [17, 18]. These observations, together with our data indicating that the kidney and brain specimens obtained from negative control rats were negative for L. interrogans DNA by PCR, argue strongly for the validity of the PCR assay used in our study.
Recent changes in the recognized patterns of infectious disease epidemiology have raised public awareness of emerging diseases (such as Lyme borreliosis, the hantavirus pulmonary syndrome, and ehrlichiosis) [19] and reemerging diseases (such as bartonellosis) [20, 21]. As with the recent cases of trench fever in urban homeless persons and alcoholics [20, 21], newly applied diagnostic methods can alert clinicians and public health officials to previously unrecognized diseases [22]. Many inner cities continue to decay socially and economically, which allows the establishment or expansion of reservoir hosts of diseases (such as rats) and potentially leads to the establishment of an endemic substrate for the spread of disease. Our results suggest that leptospirosis may be yet another reemerging infectious disease in urban areas of the United States.
Presented in part at the American College of Physicians' Annual Session, Associates' Poster Competition, March 1995.
Dr. Glass: Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health and Hygiene, 615 North Wolfe Street, Room 4307-A, Baltimore, MD 21205.
Dr. Flexner: Johns Hopkins School of Medicine, 600 North Wolfe Street, Osler 524, Baltimore, MD 21287.
Dr. Mueller: Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Dr. Kaslow: National Institutes of Health, Building 4, Room B1-31, Bethesda, MD 20892-0425.
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Torten M, Marshall RB. Leptospirosis. In: Beran GW, Steele JH, eds. Handbook of Zoonoses. 2d ed. Boca Raton, FL: CRC Pr; 1994:245-64.
2. Farr RW. Leptospirosis. Clin Infect Dis. 1996; 21:1-8.
3. Edwards GA, Domm BM. Human leptospirosis. Medicine (Baltimore). 1964; 39:117-56.
4. Health CW, Alexander AD, Galton MM. Leptospirosis in the United States. N Engl J Med. 1965; 273:857-64.
5. Sasaki DM, Pang L, Minette HP, Wakida CK, Fujimoto WJ, Manea SJ, et al. Active surveillance and risk factors for leptospirosis in Hawaii. Am J Trop Med Hyg. 1993; 48:35-43.
6. Cacciapuoti B, Ciceroni L, Pinto A, Apollini M, Rondinella V, Bonomi U, et al. Survey on the prevalence of leptospira infections in the ltalian population. Eur J Epidemiol. 1994; 10:173-80.
7. Outbreak of acute febrile illness and pulmonary hemorrhageNicaragua, 1995. MMWR Morb Mortal Wkly Rep. 1995; 44:841-3.
8. Zaki SR, Shieh WJ. Leptospirosis associated with outbreak of acute febrile illness and pulmonary haemorrhage, Nicaragua, 1995. The Epidemic Working Group at Ministry of Health in Nicaragua [Letter]. Lancet. 1996; 347:535.
9. Gravekamp C, Van de Kemp, Franzen M, Carrington D, Schoone GJ, Van Eys GJ, et al. Detection of seven species of pathogenic leptospires by PCR using two sets of primers. J Gen Microbiol. 1993; 139:1691-700.
10. Starr L, Quaranta V. An efficient and reliable method for cloning PCR-amplification products: a survey of point mutations in integrin cDNA. Biotechniques. 1992; 13:612-8.
11. Cole JR Jr, Sulzer CR, Pursell AR. Improved microtechnique for the leptospiral microscopic agglutination test. Appl Microbiol. 1973; 25:976-80.[Medline]
12. Summary of notifiable diseases, United States 1993. MMWR Morb Mortal Wkly Rep. 1994; 42:36.
13. Childs JE, Schwartz BS, Ksiazek TG, Graham RR, LeDuc JW, Glass GE. Risk factors associated with antibodies to leptospires in inner-city residents of Baltimore: a protective role for cats. Am J Public Health. 1992; 82:597-9.
14. Demers RY, Thiermann A, Demers P, Frank R. Exposure to Leptospira icterohaemorrhagiae in inner-city and suburban children: a serologic comparison. J Fam Pract. 1983; 17:1006-11.
15. Merlen F, Baranton G, Perolat P. Comparison of polymerase chain reaction with microagglutination test and culture for diagnosis of leptospirosis. J Infect Dis. 1995; 172:281-5.
16. Feigin RD, Lobes LA Jr, Anderson D, Pickering L. Human leptospirosis from immunized dogs. Ann Intern Med. 1973; 79:777-85.
17. Epidemiologic notes and reports. LeptospirosisNew York. MMWR Morb Mortal Wkly Rep. 1972; 21:401-2.
18. Babudieri B. Animal reservoirs of leptospirosis. Ann N Y Acad Sci. 1958:70; 393-413.
19. Morse SS. Factors in the emergence of infectious diseases. Emerging Infectious Diseases. 1995; 1:7-15.
20. Drancourt M, Mainardi JL, Brouqui P, Vandenesch F, Carta A, Lehnert F, et al.Bartonella (Rochalimaea) quintana endocarditis in three homeless men. N Engl J Med. 1995; 332:419-23.
21. Spach DH, Kanter AS, Dougherty MJ, Larson AM, Coyle MB, Brenner DJ, et al.Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med. 1995; 332:424-8.
22. Relman DA. Has trench fever returned? [Editorial] N Engl J Med. 1995; 332:463-4.
This article has been cited by other articles:
![]() |
S. Viriyakosol, M. A. Matthias, M. A. Swancutt, T. N. Kirkland, and J. M. Vinetz Toll-Like Receptor 4 Protects against Lethal Leptospira interrogans Serovar Icterohaemorrhagiae Infection and Contributes to In Vivo Control of Leptospiral Burden Infect. Immun., February 1, 2006; 74(2): 887 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. NARITA, S. FUJITANI, D. A. HAAKE, and D. L. PATERSON LEPTOSPIROSIS AFTER RECREATIONAL EXPOSURE TO WATER IN THE YAEYAMA ISLANDS, JAPAN Am J Trop Med Hyg, October 1, 2005; 73(4): 652 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Karande, M Bhatt, A Kelkar, M Kulkarni, A De, and A Varaiya An observational study to detect leptospirosis in Mumbai, India, 2000 Arch. Dis. Child., December 1, 2003; 88(12): 1070 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. RUSSELL, M. A. M. GONZALEZ, D. M. WATTS, R. C. LAGOS-FIGUEROA, G. CHAUCA, M. ORE, J. E. GONZALEZ, C. MORON, R. B. TESH, and J. M. VINETZ AN OUTBREAK OF LEPTOSPIROSIS AMONG PERUVIAN MILITARY RECRUITS Am J Trop Med Hyg, July 1, 2003; 69(1): 53 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Guerreiro, J. Croda, B. Flannery, M. Mazel, J. Matsunaga, M. G. Reis, P. N. Levett, A. I. Ko, and D. A. Haake Leptospiral Proteins Recognized during the Humoral Immune Response to Leptospirosis in Humans Infect. Immun., August 1, 2001; 69(8): 4958 - 4968. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Levett Leptospirosis Clin. Microbiol. Rev., April 1, 2001; 14(2): 296 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Nally, J. F. Timoney, and B. Stevenson Temperature-Regulated Protein Synthesis by Leptospira interrogans Infect. Immun., January 1, 2001; 69(1): 400 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Barocchi, A. I. Ko, S. R. Ferrer, M. T. Faria, M. G. Reis, and L. W. Riley Identification of New Repetitive Element in Leptospira interrogans Serovar Copenhageni and Its Application to PCR-Based Differentiation of Leptospira Serogroups J. Clin. Microbiol., January 1, 2001; 39(1): 191 - 195. [Abstract] [Full Text] |
||||
![]() |
D. A. Haake, M. K. Mazel, A. M. McCoy, F. Milward, G. Chao, J. Matsunaga, and E. A. Wagar Leptospiral Outer Membrane Proteins OmpL1 and LipL41 Exhibit Synergistic Immunoprotection Infect. Immun., December 1, 1999; 67(12): 6572 - 6582. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Haake, C. Martinich, T. A. Summers, E. S. Shang, J. D. Pruetz, A. M. McCoy, M. K. Mazel, and C. A. Bolin Characterization of Leptospiral Outer Membrane Lipoprotein LipL36: Downregulation Associated with Late-Log-Phase Growth and Mammalian Infection Infect. Immun., April 1, 1998; 66(4): 1579 - 1587. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||